Is XRP Too Risky to Own -- or Too Cheap to Ignore? Despite off-the-charts future growth forecasts, XRP continues to trade for a price near $1.
Why Embecta Stock Plummeted Today Embecta's most recent quarterly report didn't give investors much to be exicited about.
Why Rhythm Pharmaceuticals Stock Triumphed on Tuesday It released an encouraging quarterly earnings report and business update before market open.
Why Marvell Stock Soared 67% in April Last month, shares of the custom AI chipmaker got a boost from a Nvidia partnership and investment, a potential collaboration with Google, and an acquisition.
Why Slide Insurance's CRO sold when he did has nothing to do with the stock This Tampa-based insurer specializing in residential property coverage reported significant insider selling in its latest SEC filing.
This Fund Disclosed Selling $18 Million in Alphatec Last Quarter. The Stock Just Tanked 20% After Earnings This medical technology firm provides spinal surgery solutions to U.S. hospitals and surgical centers through proprietary devices.
